BlackRock’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.99M Buy
3,369,670
+3,115,135
+1,224% +$4.61M ﹤0.01% 3712
2025
Q1
$652K Buy
254,535
+29,878
+13% +$76.5K ﹤0.01% 4272
2024
Q4
$422K Buy
224,657
+45,873
+26% +$86.2K ﹤0.01% 4399
2024
Q3
$182K Sell
178,784
-154,387
-46% -$157K ﹤0.01% 4493
2024
Q2
$390K Sell
333,171
-2,977,346
-90% -$3.48M ﹤0.01% 4356
2024
Q1
$4.17M Sell
3,310,517
-147,217
-4% -$185K ﹤0.01% 3691
2023
Q4
$6.15M Buy
3,457,734
+282,272
+9% +$502K ﹤0.01% 3534
2023
Q3
$5.27M Buy
3,175,462
+534,491
+20% +$887K ﹤0.01% 3583
2023
Q2
$5.28M Buy
2,640,971
+2,524,828
+2,174% +$5.05M ﹤0.01% 3633
2023
Q1
$244K Buy
116,143
+14,250
+14% +$29.9K ﹤0.01% 4638
2022
Q4
$140K Buy
101,893
+3,130
+3% +$4.29K ﹤0.01% 4865
2022
Q3
$103K Sell
98,763
-2,790
-3% -$2.91K ﹤0.01% 5078
2022
Q2
$111K Sell
101,553
-7,508
-7% -$8.21K ﹤0.01% 5124
2022
Q1
$116K Sell
109,061
-5,337
-5% -$5.68K ﹤0.01% 5165
2021
Q4
$95K Sell
114,398
-5,157
-4% -$4.28K ﹤0.01% 5210
2021
Q3
$159K Sell
119,555
-2,944
-2% -$3.92K ﹤0.01% 4969
2021
Q2
$234K Buy
122,499
+121,128
+8,835% +$231K ﹤0.01% 4799
2021
Q1
$6K Buy
+1,371
New +$6K ﹤0.01% 5060
2020
Q4
Sell
-6,284
Closed -$24K 5040
2020
Q3
$24K Hold
6,284
﹤0.01% 4593
2020
Q2
$24K Buy
+6,284
New +$24K ﹤0.01% 4584
2017
Q4
Sell
-9,420
Closed -$55K 4914
2017
Q3
$55K Hold
9,420
﹤0.01% 4394
2017
Q2
$79K Sell
9,420
-810
-8% -$6.79K ﹤0.01% 4374
2017
Q1
$139K Buy
+10,230
New +$139K ﹤0.01% 4224
2015
Q2
Sell
-33,956
Closed -$604K 3204
2015
Q1
$604K Hold
33,956
﹤0.01% 1466
2014
Q4
$625K Hold
33,956
﹤0.01% 1285
2014
Q3
$822K Sell
33,956
-2,750
-7% -$66.6K ﹤0.01% 1222
2014
Q2
$1.34M Hold
36,706
﹤0.01% 1111
2014
Q1
$1.68M Hold
36,706
﹤0.01% 1075
2013
Q4
$1.43M Buy
+36,706
New +$1.43M ﹤0.01% 1082